HTL Strefa

Supervisory board

Gerard van Odijk

Chairman of the Supervisory Board

Gerardus van Odijk has over 25 years of experience in the European healthcare industry. Up until 2012, Mr van Odijk was the CEO of Teva Pharmaceuticals Europe – a global leader in pharmaceuticals with revenue of approximately $20bn and over 42,000 employees.
Mr. van Odijk has also held various senior management positions with GSK Plc, most recently holding the position of SVP and Area Director Northern Europe.
Mr. van Odijk is currently the Chairman of Bavarian Nordic and a Non-Executive Director of UDG.
Gerard has degree of Medical Doctor from the University of Utrecht.

Heino von Prondzynski

Vice-Chairman of the Supervisory Board

Heinz Norbert Ferdinand Maria von Prondzynski studied mathematics and geography at the Westfälische Wilhelms University.
Mr. von Prondzynski held the positions of a CEO in Bayer Diagnostics AG from 1989 to 1996, of the President & CEO in Chiron Corporation, Chiron Behring GmbH, Chiron S.A. from 1996 to 2000 and subsequently of a CEO in F. Hoffmann La Roche Ltd, Div. Diagnostics from 2000 to 2006.
Currently, Mr. von Prondzynski is a Member of the Supervisory Board in Royal Philips from 2007, a Chairman of the Board of Directors in Epigenomics AG from 2012 and Independent Lead Director of Quotient Ltd from 2014.
Mr. von Prondzynski is the Vice-Chairman of the Supervisory Board in HTL-Strefa S.A. as well as a member of Audit Committee.

Mads Ditlevsen

Member of the Supervisory Board

Mr. Mads Ditlevsen joined EQT Partners in January 2004. He has since then been based in both Copenhagen and Hong Kong, where he worked for the EQT Greater China fund.
He currently serves as a board member of Færch Plast and HusCompagniet. He was also part of the deal teams on the Contex, Atos Medical, IHI, CaridianBCT, Dako, Tiger, TOP-TOY and Qinterra transactions.
Mr Ditlevsen holds a M. Sc. in Finance and Accounting from Copenhagen Business School and Case Western Reserve University, Ohio. He is also involved with Copenhagen Business School, where he acts as supervisor and examiner on M. Sc. dissertations.

Wojciech Wyszogrodzki

Member of the Supervisory Board

Wojciech Wyszogrodzki graduated from the Technical University of Łódź in 1972 with a Master engineer degree in automatics and electronics.
Mr. Wyszogrodzki has started his career in 1972 in Industrial Research Institute for Automation and Measurements where he was a scientific worker. He worked at PZ Karimex as the Electronic Production Director. In 1995 he began working for PZ HTL S.A. as a General Manager, where he worked from 1995 to 2007 as the President of the Management Board.
In HT Lancet sp. z o.o. from 2005 to 2009 he was a member of the Management Board and from 2009 to 2011 he held the position of the President of the Management Board. From 2011 to 2013 he acted as an advisor to the President of the Management Board in HT Lancet sp. z o.o.
In HTL-Strefa S.A. from 2006 to 2009, Mr. Wyszogrodzki was a General Director. Subsequently, from 2009 to 2011 he held the position of the President of the Management Board in HTL-Strefa S.A.
Mr. Wyszogrodzki is a Member of the Supervisory Board of HTL-Strefa S.A. from 2011 and a member of the audit committee. Mr. Wyszogrodzki is also a member of the Management Board of Sparrow 6 sp. z o.o. from 2015.

Nicolas Nemery

Member of the Supervisory Board

Nicolas Nemery holds a Bachelor and a M.Sc. in Business Administration from Copenhagen Business School as well as a Bachelor in Public Administration and Political Science from Copenhagen University.
Mr. Nemery started his career at Procter & Gamble in Stockholm and then became a Senior Consultant at McKinsey & Company in Copenhagen. Subsequently, he worked at Novo Nordisk A/S for 10 years, most of the time as the Vice President of Global Marketing responsible for the diabetes strategy and the global launches of insulin analogues and devices. After Novo Nordisk, Mr. Nemery joined LifeCycle Pharma as the Senior Vice President of Commercial Operations, and then he went on to work for Coloplast A/S, as Vice President and Senior Vice President of Global Marketing. In addition, Mr. Nemery has been an Associate Professor of Marketing at Copenhagen Business School.
Mr. Nemery has been a member of the board of directors of Curasight ApS and he has been a member of the Supervisory Board of HTL-Strefa S.A. since July 2015. He is also the chairman of the Audit Committee and a member of the Remuneration Committee.

Richard Thomas Cook

Member of the Supervisory Board

Richard Thomas Cook has over 35 years experience in Operations with the Medical Device / IV Solutions industries. He graduated from Georgia College with dual degrees in Management and Economics.
He spent 12 years with McGaw Laboratories, originally aligned under American Hospital Supply Corporation and later under the Kendall Corporation.
Mr. Cook then joined Becton Dickinson where he held numerous roles over his 25-year career, culminating as Vice President, Global Manufacturing. During his tenure, Mr. Cook was, on 2 occasions, asked to serve as Interim President for one of the worldwide business units of Becton Dickinson.
Mr. Cook has been an Industrial Advisor with EQT since his retirement in 2013.